HOME >> BIOLOGY >> NEWS
The future of HIV therapeutics is brightening, according to Gladstone Institutes Director

Recent discoveries about the way that HIV infects cells are propelling the development of a broad spectrum of promising new antiviral drugs, according to an invited commentary on the topic in the current issue of Nature Immunology (August 27, 2004).

The assessment is made by Gladstone Institute of Virology and Immunology (GIVI) Director Warner Greene, MD, PhD, who also serves as professor of medicine, microbiology and immunology at the University of California, San Francisco.

In the piece, Greene points out that basic research on HIV, a relatively simple pathogen with only nine genes encoding 15 proteins, are leading to compelling new therapies that deny the initial entry of HIV into its cellular host. In addition, fast-moving research of naturally occurring factors with potent antiviral properties is opening the way for future development of an entirely new class of anti-HIV drugs.

New agents that block the first step in HIV's life cycle, the entry of the HIV virion (a single virus particle) into host CD4 T-cells, are quickly moving down the drug development pipeline. Chief among these therapeutics are drugs known as chemokine receptor antagonists that interfere with HIV's ability to bind to CCR5, one of two key surface receptors needed for the virus to penetrate the cell. Although these HIV co-receptors were identified only seven years ago, basic studies performed by both GIVI investigators and scientists around the world have helped accelerate clinical development of CCR5 antagonists as a new class of anti-HIV drugs. Several major pharmaceutical companies are now racing to the finishing line.

These advances address but one of the three steps required for successful entry of the HIV virus. The other two steps involve the attachment of HIV virions to surface CD4 receptors and the final fusion of virions to target cells. These steps are also being targeted with new antiviral drugs. Combinations of inhibitors acting at each o
'"/>

Contact: John Watson
jwatson@gladstone.ucsf.edu
415-695-3833
University of California - San Francisco
27-Aug-2004


Page: 1 2 3

Related biology news :

1. New fruitfly model of diabetes has future implications for pancreatic cell transplantation
2. Charting the future in prostate cancer care: A call to action
3. Sandia experiments may reduce possibility of future water wars
4. Will a reduction in military spending improve our environmental future?
5. Engineering endurance: The future of the Olympics?
6. The future of nanotechnology
7. Chemoradioimmunotherapy for advanced breast cancer: hope for the future?
8. Endometriosis: Could angiostatic therapy be the new treatment of the future?
9. Plants for the future: A European vision for plant biotechnology towards 2025
10. Plant pathologists to discuss the future of organic farming
11. Stem cells commit to a future of fat with one signal

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/4/2019)... ... April 02, 2019 , ... The live ... provide insight into the connectivity between product risk management (ISO 14971) and the ... supporting this process. , With increasing global regulation and reimbursement challenges faced by ...
(Date:4/1/2019)... ... 01, 2019 , ... Stay on top of current hot topics through free ... to all webinars is free, so be sure to register today to save your ... http://www.xtalks.com to see our upcoming webinars: , CLINICAL TRIALS , April 2 – ...
(Date:3/29/2019)... ... March 29, 2019 , ... RoosterBio, Inc, a ... the Society for Biomaterials Annual Meeting & Exposition on April 3-6, 2019 in ... academic, healthcare, governmental and business professionals in all aspects of the biomaterial science ...
Breaking Biology News(10 mins):
(Date:3/27/2019)... ... March 27, 2019 , ... In honor of National Nutrition Month, ... importance of healthy meals and good nutrition. This month, Chef Jodi Abel appeared ... chef. , The first segment addressed the nutritional value of USDA’s MyPlate, ...
(Date:3/23/2019)... ... March 22, 2019 , ... Tosoh Bioscience LLC ... (MALS) detector , offering a revolutionary approach for the measurement of molecular weight ... A novel optical design, a unique cell-block assembly, and a new calculation methodology ...
(Date:3/19/2019)... ... March 19, 2019 , ... Bogey was nine years old when he injured both of his ... These ailments caused Bogey to experience problems with his mobility. According to his ... his special spot on the couch. , His owners, devastated at the sight of Bogey ...
(Date:3/19/2019)... GAN, Israel and BASEL, Switzerland (PRWEB) , ... ... ... Sheba Medical Center at Tel HaShomer, the largest hospital in Israel ... to develop point-of-care cell-therapy manufacturing using the state-of-the-art Cocoon™ manufacturing platform. The ...
Breaking Biology Technology:
Cached News: